Advertisement

Topics

Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs

10:26 EDT 23 Aug 2017 | Labiotech.eu

Boehringer Ingelheim starts two new Phase I trials with drugs intended to treat type 2 diabetes and obesity discovered through a partnership with Danish biotech Zealand.  The new Phase I trials initiated by Boehringer Ingelheim will be conducted in Germany, ...

This awesome article Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs

NEXT ARTICLE

More From BioPortfolio on "Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...